from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2828c/-

LFCtreatmentdescriptionclass of inhibitor

-0.179

Amikacinug/mL Amikacintranslation

-0.370

Cap5-10ug/mL Capreomycintranslation

0.686

Rox10-50 ug/mL Roxithromycintranslation

0.407

SM2-5 ug/mL Streptomycintranslation

0.694

Tet5-10 ug/mL Tetracyclinetranslation

-0.755

Rif0.2-5ug/mL Rifampicintranscription

-0.656

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.713

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.096

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.542

CPZ10-50 ug/mL Chlorpromazinerespiration

0.757

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.014

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.687

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.339

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.488

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.001

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.318

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.348

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.473

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.077

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.020

KCN5-20 ug/mL Potassium cyaniderespiration

0.666

NaN30.2-2 mM Sodium aziderespiration

-0.458

Nigericin50 uM Nigericinrespiration

0.262

TRC10-150 ug/mL Triclosanrespiration

0.171

TRZ10-25 ug/mL Thioridazinerespiration

1.930

Valinomycin0.5-10 uM Valinomycinrespiration

-0.301

ZnSO42 mM ZnSO4respiration

-0.303

menadione6-10 ug/mL Menadionerespiration

-0.386

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.469

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.673

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.795

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.356

NRP_1Non-replicating persistence stage 1dosRassociated

-0.135

Amp0.2mg/mL AmpicillincellWall

-0.432

Cephalexin20-100 ug/mL CephalexincellWall

-0.677

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.571

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.894

EMB10-20 ug/mL EthambutolcellWall

-0.380

Eta12-40 ug/mL EthionamidecellWall

-0.343

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.782

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.300

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.353

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.894

BZA0.12 mg/mL BenzamidearomaticAmides

0.239

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.458

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.495

H2O24 mM hydrogen peroxideDNAdamaging

-0.861

Levo10 ug/mL LevofloxacinDNAdamaging

-0.468

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.375

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.908

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.337

UVUV-irradiationDNAdamaging

0.199

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.704

Antimycin12.5-50 ug/mL Antimycin A?

-0.579

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.321

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.648

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.202

PA8240.2-2 ug/mL PA-824?

2.473

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.679

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.260

Verapamil50 uM Verapamil?

-0.322

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.237

methoxatin10-20 ug/mL Methoxatin?